Publication: Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old
Issued Date
2004-05-07
Resource Type
ISSN
0264410X
Other identifier(s)
2-s2.0-2342644906
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Vaccine. Vol.22, No.15-16 (2004), 2018-2022
Suggested Citation
Kulkanya Chokephaibulkit, Wanatpreeya Phongsamart, Nirun Vanprapar, Tawee Chotpitayasunondh, Sanay Chearskul Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old. Vaccine. Vol.22, No.15-16 (2004), 2018-2022. doi:10.1016/j.vaccine.2003.10.033 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/21187
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Catch-up vaccination against Haemophilus influenzae type b in human immunodeficiency virus-infected Thai children older than 2 years old
Other Contributor(s)
Abstract
Although most of Thai children older than 2 years are immune against Haemophilus influenzae type b (Hib) without prior vaccination, it may not be the case in HIV-infected children. Of 44 HIV-infected children tested before vaccination at the mean age of 36 months (range 24-84 months), 32 (73%) were susceptible (anti-PRP <0.15 μg/ml). At 6 months after a single dose of tetanus-conjugated Hib vaccination, 67% developed anti-PRP ≥0.15 μg/ml, however, only 33% developed titer of ≥1 μg/ml. Four of seven (57%) with anti-PRP 0.15-0.99 μg/ml at baseline were boosted to the titer of ≥1 μg/ml after vaccination. Seroconversion rate and geometric mean titer (GMT) level in response to the vaccination did not correlate with HIV stage, but did correlate with viral load level of 100,000 copies/ml. HIV-infected children older than 2 years would benefit from Hib vaccination, although, one dose catch-up schedule is not sufficient in a third of these children. A second dose is needed in these children especially those with viral load of level of >100,000 copies/ml. © 2003 Elsevier Ltd. All rights reserved.